Polar Capital Holdings Plc - Jun 30, 2025 SCHEDULE 13G Report for ENLIVEN THERAPEUTICS, INC. Common Stock, $0.001 par value per share (ELVN)

Filing Manager
Polar Capital Holdings Plc
Reporting Manager
Polar Capital Holdings Plc
Security
ENLIVEN THERAPEUTICS, INC. Common Stock, $0.001 par value per share
Symbol
ELVN
Shares outstanding
49.1M shares
Disclosed Ownership
2.54M shares
Ownership
5.17%
Form type
SCHEDULE 13G
Date filed
8/14/2025, 08:01 AM
Date of event
Jun 30, 2025
Previous filing
Feb 14, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Polar Capital Holdings Plc 5.17% 2.54M 2.54M 0 /s/ Nicholas Farren Nicholas Farren - Chief Operating Officer
Polar Capital LLP 5.17% 2.54M 2.54M 0 /s/ Nicholas Farren Nicholas Farren - Chief Operating Officer
Polar Capital Funds PLC - Biotechnology Fund 5.17% 2.54M 2.54M 0 /s/ Nicholas Farren Nicholas Farren - Chief Operating Officer